REGN Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals, Inc. (REGN) is currently at $802.50, up $51.20 or 6.81%

--Would be new all-time high (Based on available data back to April 2, 1991)

--On pace for largest percent increase since Sept. 8, 2022, when it rose 18.85%

--Currently up three of the past four days

--Up 5.53% month-to-date; on pace for best month since Oct. 2022, when it rose 8.69%

--Up 11.23% year-to-date

--Up 18.06% from 52 weeks ago (March 24, 2022), when it closed at $679.76

--Would be a new 52-week closing high

--Up 46.35% from its 52-week closing low of $548.35 on June 14, 2022

--Traded as high as $812.69; new all-time intraday high (Based on available data back to April 2, 1991)

--Up 8.17% at today's intraday high; largest intraday percent increase since Sept. 8, 2022, when it rose as much as 20.54%

--Third best performer in the S&P 500 today

--Second best performer in the Nasdaq 100 today

All data as of 11:45:27 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

March 23, 2023 12:03 ET (16:03 GMT)

Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2024 to May 2024

Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From May 2023 to May 2024